Item 1.01 Entry into a Material Definitive Agreement.
On
Borrowings under the Revolving Credit Facility are available for working capital, capital expenditures, acquisitions and other lawful corporate purposes. No proceeds from the Revolving Credit Facility were drawn down as of the closing date of the Credit Agreement.
Revolving loans under the Credit Agreement (other than swing line loans) will
bear interest at rate per annum equal to a Eurocurrency Rate - for dollars,
euros, sterling and yen, the London Interbank Offered Rate ("LIBOR") or for any
other currency approved pursuant to the terms of the Credit Agreement, at the
rate designated at the time of such approval, in each case subject to a floor of
0.00% per annum, plus an applicable margin ranging from 0.750% to 1.375%
depending on the ratings of the Company's non-credit enhanced, senior unsecured
long-term debt, as determined by either
In addition to paying interest on any outstanding principal under the Revolving Credit Facility, the Company will pay (i) a commitment fee in respect of the unutilized commitments thereunder and (ii) customary letter of credit fees and agency fees. The commitment fees range from 0.050% to 0.175% per annum based on the Company's Debt Ratings.
The Revolving Credit Facility will terminate and all amounts outstanding thereunder are due and payable five years after the closing date, subject to certain extension options as set forth in the Credit Agreement. Under the Revolving Credit Facility, voluntary prepayments are permitted, in whole or in part, in minimum amounts without premium or penalty, other than customary breakage costs with respect to Eurocurrency borrowings. The Revolving Credit Facility requires quarterly interest payments or, in the case of Eurocurrency borrowings, at the end of the interest period therefor, with the principal due on the maturity date.
The Credit Agreement contains customary representations and warranties, affirmative and negative covenants and events of default. The Credit Agreement also includes a financial covenant requiring the Company to maintain, measured as of the end of each fiscal quarter, a maximum consolidated leverage ratio of 3.5 to 1.0 (which may be temporarily increased to 4.0 to 1.0 upon the election of the Company as a result of a material acquisition, subject to customary limitations).
A copy of the Credit Agreement is attached hereto as Exhibit 10.1 and is incorporated herein by reference. The description of the Credit Agreement is a summary only and is qualified in its entirety by the terms of the Credit Agreement.
Item 1.02 Termination of a Material Definitive Agreement.
Simultaneously with the Company's entry into the Credit Agreement, it repaid in
full all outstanding obligations under, and terminated, its existing Credit
Agreement, dated as of
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information included in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.
2
--------------------------------------------------------------------------------
Item 9.01 Financial Statements and Exhibits.
The exhibit listed below is furnished as part of this Current Report on Form 8-K. Exhibit No. Description Exhibit 10.1 Credit Agreement, dated as ofJanuary 28, 2020 , amongBiogen Inc. ,Bank of America, N.A ., as administrative agent, swing line lender and the L/C issuer, and the other lenders party thereto 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 3
--------------------------------------------------------------------------------
© Edgar Online, source